Covid-19: Scientists to trial combination of Oxford-AstraZeneca and Russian vaccines

The trials will involve people aged 18 and over, AstraZeneca said on Friday

A researcher in a laboratory at the Jenner Institute working on the coronavirus vaccine developed by AstraZeneca and Oxford University. Picture: John Cairns/University of Oxford

AstraZeneca is to join a trial exploring whether a combination of its Covid-19 vaccine candidate and the Russian Sputnik V jab can offer improved protection from coronavirus.

The pharmaceutical giant, which is developing the AZD1222 vaccine with Oxford University, said it would collaborate with the Russian Gamaleya Research Institute.